Core Insights - The medical device industry is facing a "tool gap" between hardware evolution and backend service support capabilities, leading to a fusion ecosystem of "hardware + services + intelligence" as a key strategy for companies to build competitive advantages [1] - Xiangsheng Medical has launched its self-developed AI assistant application, CHISON Pilot, globally, marking a significant leap in its service support system following the smart upgrade of ultrasound mainframes [1][2] Group 1: AI Assistant CHISON Pilot - CHISON Pilot is designed to bridge the gap between advanced hardware and fragmented support services, providing real-time, precise, and personalized information integration and decision support for sales, clinical, and end-users [2] - The application is available on Google Play and Apple App Store, covering 176 countries and regions, and is not just a simple tool but a critical product aimed at enhancing service efficiency [2][3] - CHISON Pilot features three intelligent modules that deliver differentiated value in sales support, clinical assistance, and user services, evolving from a passive tool to an active AI partner that understands user preferences over time [3] Group 2: SonoAI and Intelligent Service Ecosystem - Xiangsheng Medical has established a comprehensive intelligent standard framework for ultrasound AI diagnosis, driven by a dual-engine approach of "ultrasound AI + specialized models," covering the entire process from equipment development to diagnostic decision-making [4] - The SonoAI solution has been integrated into the SonoFamily product line, enabling intelligent scanning, precise measurement, assisted diagnosis, and automated reporting across key clinical areas [4] - The company has made significant advancements in breast ultrasound AI diagnostic systems, achieving improved accuracy in BI-RADS classification and benign/malignant differentiation, supporting large-scale breast cancer screening with high sensitivity and specificity [4][5] Group 3: Strategic Implications - The continuous launch of intelligent solutions like SonoAI and CHISON Pilot is helping Xiangsheng Medical build a closed-loop intelligent ecosystem from hardware to services, enhancing product competitiveness and pushing ultrasound medicine towards standardized, replicable intelligent decision-making [5] - The company's ongoing technological innovations in AI applications are reshaping the application paradigm and value boundaries of ultrasound devices, injecting new momentum into its global market expansion [5]

Core Insights - The National Health Commission, along with other governmental bodies, released implementation opinions to promote and regulate the application of "Artificial Intelligence + Healthcare," emphasizing the importance of AI in clinical diagnosis and medical imaging [2] Group 1: Policy and Market Opportunities - The implementation opinions encourage the promotion of intelligent diagnostic services in medical imaging, supporting provincial-level coordination for AI-assisted diagnosis and treatment recommendations [2] - The policy is expected to provide significant development opportunities for companies like Xiangsheng Medical, which specializes in intelligent ultrasound imaging [2] Group 2: Company Innovations and Developments - Xiangsheng Medical has been a pioneer in the ultrasound AI diagnosis field, integrating large models and deep learning algorithms to address core technical challenges [3] - The company has launched the SonoAI solution, which covers various ultrasound clinical applications and enhances diagnostic efficiency through intelligent scanning and automated reporting [3] - The upcoming breast ultrasound intelligent auxiliary diagnosis system is set to improve accuracy in cancer screening, reinforcing the company's technological advantage in early detection [3][5] Group 3: R&D Investments and Future Plans - Xiangsheng Medical is increasing its R&D investments, with expenditures reaching 56.57 million yuan in the first three quarters of 2025, accounting for 16.48% of its revenue [6] - The company plans to integrate its visual recognition and robotic control technologies with AI-assisted screening systems to create new pathways for mass cancer screening [5] - The development of an "AI + Robot" system aims to enhance the efficiency and accuracy of ultrasound diagnostics, positioning the company for continued growth in the intelligent healthcare sector [4][5]